Lyon Street Capital, LLC - TRINITY BIOTECH PLC ownership

TRINITY BIOTECH PLC's ticker is TRIB and the CUSIP is 896438306. A total of 92 filers reported holding TRINITY BIOTECH PLC in Q2 2014. The put-call ratio across all filers is 10.06 and the average weighting 0.3%.

Quarter-by-quarter ownership
Lyon Street Capital, LLC ownership history of TRINITY BIOTECH PLC
ValueSharesWeighting
Q3 2015$1,612,000
-48.5%
140,943
-18.7%
1.17%
-48.1%
Q2 2015$3,133,000
-71.5%
173,459
-69.6%
2.25%
-52.4%
Q1 2015$10,980,000
-28.0%
570,387
-34.6%
4.73%
-25.5%
Q4 2014$15,259,000
+12.9%
872,254
+17.9%
6.34%
+0.2%
Q3 2014$13,514,000
-99.9%
739,669
+15.7%
6.33%
-2.4%
Q2 2014$14,723,000,000
+8.5%
639,291
+14.2%
6.49%
+3.3%
Q1 2014$13,570,000,000
+20.2%
560,039
+24.7%
6.28%
+23.7%
Q4 2013$11,290,000,000
+27.3%
449,067
+10.2%
5.08%
+16.1%
Q3 2013$8,870,047,000
+42.7%
407,586
+10.5%
4.37%
+42.1%
Q2 2013$6,215,257,000368,8583.08%
Other shareholders
TRINITY BIOTECH PLC shareholders Q2 2014
NameSharesValueWeighting ↓
Prospect Capital Advisors, LLC 336,550$3,924,0004.65%
ACK Asset Management 979,600$11,422,0004.49%
Balter Liquid Alternatives, LLC 161,284$1,881,0004.33%
GOLDMAN CAPITAL MANAGEMENT INC 396,690$4,625,0003.50%
Paradice Investment Management LLC 1,435,724$16,741,0002.23%
Adirondack Research & Management Inc. 415,353$4,843,0001.76%
Lapides Asset Management, LLC 705,100$8,221,0001.47%
Park West Asset Management LLC 900,000$10,494,0000.99%
Benchmark Capital Advisors 83,541$974,0000.86%
HEARTLAND ADVISORS INC 1,290,010$15,042,0000.79%
View complete list of TRINITY BIOTECH PLC shareholders